These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 31572351

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G, Correia-Neves M, Buteme H, Hamasur B, Svenson SB.
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [Abstract] [Full Text] [Related]

  • 3. Polysaccharides and glycolipids of Mycobacterium tuberculosis and their induced immune responses.
    Gong Y, Wang J, Li F, Zhu B.
    Scand J Immunol; 2023 May; 97(5):e13261. PubMed ID: 39008002
    [Abstract] [Full Text] [Related]

  • 4. Liposomal delivery of lipoarabinomannan triggers Mycobacterium tuberculosis specific T-cells.
    Kallert S, Zenk SF, Walther P, Grieshober M, Weil T, Stenger S.
    Tuberculosis (Edinb); 2015 Jul; 95(4):452-62. PubMed ID: 26043674
    [Abstract] [Full Text] [Related]

  • 5. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis.
    Torrelles JB, Khoo KH, Sieling PA, Modlin RL, Zhang N, Marques AM, Treumann A, Rithner CD, Brennan PJ, Chatterjee D.
    J Biol Chem; 2004 Sep 24; 279(39):41227-39. PubMed ID: 15263002
    [Abstract] [Full Text] [Related]

  • 6. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J, Yasmin H, Al-Ahdal MN, Bhakta S, Kishore U.
    Immunobiology; 2020 May 24; 225(3):151951. PubMed ID: 32423788
    [Abstract] [Full Text] [Related]

  • 7. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
    Sande OJ, Karim AF, Li Q, Ding X, Harding CV, Rojas RE, Boom WH.
    J Immunol; 2016 Jan 15; 196(2):691-702. PubMed ID: 26667170
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis.
    Borrero R, García Mde L, Canet L, Zayas C, Reyes F, Prieto JL, Infante JF, Lanio ME, Kadir R, López Y, Sarmiento ME, Nor Norazmi M, Acosta A.
    BMC Immunol; 2013 Jan 15; 14 Suppl 1(Suppl 1):S13. PubMed ID: 23458474
    [Abstract] [Full Text] [Related]

  • 9. Generation of mycobacterial lipoarabinomannan-specific monoclonal antibodies and their ability to identify mycobacterium isolates.
    Yan ZH, Zhao B, Pang Y, Wang XJ, Yi L, Wang HL, Yang B, Wei PJ, Jia HY, Li SP, Zhao YL, Zhang HT.
    J Microbiol Immunol Infect; 2021 Jun 15; 54(3):437-446. PubMed ID: 32146163
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
    de Vallière S, Abate G, Blazevic A, Heuertz RM, Hoft DF.
    Infect Immun; 2005 Oct 15; 73(10):6711-20. PubMed ID: 16177348
    [Abstract] [Full Text] [Related]

  • 11. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis.
    Fukuda T, Matsumura T, Ato M, Hamasaki M, Nishiuchi Y, Murakami Y, Maeda Y, Yoshimori T, Matsumoto S, Kobayashi K, Kinoshita T, Morita YS.
    mBio; 2013 Feb 19; 4(1):e00472-12. PubMed ID: 23422411
    [Abstract] [Full Text] [Related]

  • 12. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M.
    Glatman-Freedman A, Mednick AJ, Lendvai N, Casadevall A.
    Infect Immun; 2000 Jan 19; 68(1):335-41. PubMed ID: 10603406
    [Abstract] [Full Text] [Related]

  • 13. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM, Pinn ML, Karakousis PC, Hung CF.
    Front Cell Infect Microbiol; 2018 Jan 19; 8():31. PubMed ID: 29473022
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination.
    Brown RM, Cruz O, Brennan M, Gennaro ML, Schlesinger L, Skeiky YA, Hoft DF.
    J Infect Dis; 2003 Feb 01; 187(3):513-7. PubMed ID: 12552438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
    Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, Mtei L, Vuola JM, Pallangyo K, von Reyn CF.
    Vaccine; 2010 Nov 10; 28(48):7652-8. PubMed ID: 20875492
    [Abstract] [Full Text] [Related]

  • 19. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W, Li M, Deng G, Zhao L, Liu X, Wang Y.
    Mol Med Rep; 2015 Aug 10; 12(2):3073-80. PubMed ID: 25962477
    [Abstract] [Full Text] [Related]

  • 20. Structural implications of lipoarabinomannan glycans from global clinical isolates in diagnosis of Mycobacterium tuberculosis infection.
    De P, Amin AG, Flores D, Simpson A, Dobos K, Chatterjee D.
    J Biol Chem; 2021 Nov 10; 297(5):101265. PubMed ID: 34600887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.